Convalescent plasma is an experimental procedure for COVID-19 patients. As per the guidelines, hospitals and institutions planning to provide this modality of treatment should do so in a clinical trial with protocols which are cleared by the Institutional Ethics Committee.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2y6kj9U
via IFTTT
0 comments:
Post a Comment